← Leaderboards
Judith Korner
Columbia University Health Sciences
$12,592,020
Attributed
$13,790,309
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,790,309 · 10
By mechanism
R01$10,475,428 · 3
P30$2,049,892 · 3
K08$640,710 · 1
R21$420,510 · 1
R03$163,500 · 1
M01$40,269 · 1
Top collaborators
- Sharon L. Wardlaw5 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Richard W Foltin$21,307,956
- F. Xavier Pi-Sunyer$45,280,520
- Christopher Edward Mason$16,419,065
- Ana Navas-Acien$21,953,124
- Andrea Baccarelli$24,279,074
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityBody Weight DecreasedBariatric SurgeryBody WeightHormonesGastric BypassMetabolicPlasmaDiabetes MellitusMetabolismDietBrainLeptinObesity TreatmentInnovationGlucagon-Like Peptide 1Operative Surgical ProceduresGhrelinWeight MaintenanceEffective TherapyCaloric RestrictionHungerAffectPrograms
Grant awards (45)
Association of genetic variation near the dopamine D2 receptor gene and other polymorphisms that modulate dopaminergic and opioid signaling on the weight loss response to naltrexone/bupropion$602,146
R01 · FY2025 · DK · contact PI
Pilot and Feasibility Program$193,286
P30 · FY2025 · DK · contact PI
Association of genetic variation near the dopamine D2 receptor gene and other polymorphisms that modulate dopaminergic and opioid signaling on the weight loss response to naltrexone/bupropion$642,012
R01 · FY2024 · DK · contact PI
Changes in CSF Biomarkers after Bariatric Surgery$465,943
R01 · FY2024 · DK
Pilot and Feasibility Program$194,306
P30 · FY2024 · DK · contact PI
Association of genetic variation near the dopamine D2 receptor gene and other polymorphisms that modulate dopaminergic and opioid signaling on the weight loss response to naltrexone/bupropion$592,957
R01 · FY2023 · DK · contact PI
Changes in CSF Biomarkers after Bariatric Surgery$497,960
R01 · FY2023 · DK
Pilot and Feasibility Program$193,286
P30 · FY2023 · DK · contact PI
Changes in CSF Biomarkers after Bariatric Surgery$497,960
R01 · FY2022 · DK
Pilot and Feasibility Program$193,286
P30 · FY2022 · DK · contact PI
Changes in CSF Biomarkers after Bariatric Surgery$497,960
R01 · FY2021 · DK
Metabolic and Endocrine Effects of Bariatric Surgery$375,242
R01 · FY2021 · DK · contact PI
Pilot and Feasibility Program$195,870
P30 · FY2021 · DK · contact PI
Pilot and Feasibility Program$158,217
P30 · FY2021 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$629,453
R01 · FY2020 · DK · contact PI
Changes in CSF Biomarkers after Bariatric Surgery$436,755
R01 · FY2020 · DK
Pilot and Feasibility Program$200,010
P30 · FY2020 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$671,043
R01 · FY2019 · DK · contact PI
Pilot and Feasibility Program$180,954
P30 · FY2019 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$703,016
R01 · FY2018 · DK · contact PI
Pilot and Feasibility Program$178,769
P30 · FY2018 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$498,312
R01 · FY2017 · DK · contact PI
Pilot and Feasibility Program$180,954
P30 · FY2017 · DK · contact PI
Pilot and Feasibility Program$180,954
P30 · FY2016 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$356,000
R01 · FY2015 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$356,000
R01 · FY2014 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$343,541
R01 · FY2013 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$356,000
R01 · FY2012 · DK · contact PI
Metabolic and Endocrine Effects of Bariatric Surgery$400,417
R01 · FY2011 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$100,141
R01 · FY2010 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$284,247
R01 · FY2009 · DK · contact PI
Effects of Leptin on Body Weight and Neuroendocrine Axes after Gastric Bypass$226,125
R21 · FY2009 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$284,247
R01 · FY2008 · DK · contact PI
Effects of Leptin on Body Weight and Neuroendocrine Axes after Gastric Bypass$194,385
R21 · FY2008 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$290,048
R01 · FY2007 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$291,837
R01 · FY2006 · DK · contact PI
Bariatric Surgery, Gastric Stimulation: Metabolic Effects$302,191
R01 · FY2005 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$129,222
K08 · FY2005 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$81,750
R03 · FY2005 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$129,222
K08 · FY2004 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$81,750
R03 · FY2004 · DK
Cabergoline Obesity Study$40,269
M01 · FY2004 · RR
Leptin and Neuroendocrine Gene Regulation in Obesity$129,222
K08 · FY2003 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$129,222
K08 · FY2002 · DK
Leptin and Neuroendocrine Gene Regulation in Obesity$123,822
K08 · FY2001 · DK